Allogeneic hematopoietic stem cell transplantation could improve survival for pure CBF-AML patients with minimal residual disease positive after the second consolidation.

Autor: Wang, Tanzhen1,2 (AUTHOR), Zhou, Biqi1,2 (AUTHOR), Zhang, Jubin1,2 (AUTHOR), Zhang, Xinyue1,2 (AUTHOR), Liu, Tianhui1,2 (AUTHOR), Qiu, Huiying1,2 (AUTHOR), Sun, Aining1,2 (AUTHOR), Chen, Suning1,2 (AUTHOR), Wu, Depei1,2 (AUTHOR), Xu, Yang1,2 (AUTHOR)
Zdroj: Leukemia & Lymphoma. Apr2021, Vol. 62 Issue 4, p995-998. 4p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje